Product & ReviewsAntibodies

CD276 Antibody, anti-human, APC

Clone FM276 reacts with human CD276 (B7-H3), a type I transmembrane protein expressed at low levels in human liver, lung, bladder, testis, prostate, breast, placenta, lymphoid organs, and many human cancers. Surface expression can be induced on T cells, natural killer cells, and macrophages as well as on dendritic cells (DC) by IFN-γ and on monocytes by granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin 4 (IL-4). B7-H3 has been shown to function as costimulatory molecule for T cell activation by inducing T cell proliferation and IFN-γ production.

Product Details

Cat. No.
130-095-522
Clonality
Monoclonal
Host
Mouse
Miltenyi Biotec B.V. & Co. KG

The supplier does not provide quotations for this antibody through SelectScience. You can search for similar antibodies in our  Antibody Directory.

Reviews

Average Rating 5.0

|1Scientists have reviewed this product

Specificity rating
Sensitivity rating
Quality rating
Write your own review

This CD276 antibody works perfectly for flow cytometry.

 

Average Rating 5.0

Application Area:

Flow cytometry

This CD276 antibody works perfectly, it stained the cells with high specificity.

Review Date: 18 Nov 2020 | Miltenyi Biotec B.V. & Co. KG

Applications

  • Flow Cytometry (FC)

Antibody Overview

About the company

Miltenyi Biotec B.V. & Co. KG logo

Miltenyi Biotec B.V. & Co. KG

At Miltenyi Biotec, we’re committed to empowering scientific discovery and impacting human lives. For more than 25 years, our work has played an essential role in the biomedical research and cellular therapy community. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our integrated technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, cell culture, molecular analysis, and preclinical imaging. This complete portfolio enables the access, analysis, and utilization of primary and primary-derived cells. Our expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. Today, Miltenyi Biotec has more than 1,300 employees in 22 countries.

4.3/5.0
|29 Reviews